1. Home
  2. IMRN vs UCAR Comparison

IMRN vs UCAR Comparison

Compare IMRN & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.88

Market Cap

7.7M

Sector

Health Care

ML Signal

N/A

Logo U Power Limited

UCAR

U Power Limited

N/A

Current Price

$2.80

Market Cap

6.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMRN
UCAR
Founded
1994
2013
Country
Australia
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
6.9M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
IMRN
UCAR
Price
$0.88
$2.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 22.9K
6.6K
Earning Date
08-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
N/A
$13.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.04
52 Week High
$1.99
$8.99

Technical Indicators

Market Signals
Indicator
IMRN
UCAR
Relative Strength Index (RSI) 32.67 40.98
Support Level $0.73 $1.05
Resistance Level $0.89 $4.87
Average True Range (ATR) 0.07 0.25
MACD -0.00 -0.12
Stochastic Oscillator 8.30 20.02

Price Performance

Historical Comparison
IMRN
UCAR

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: